Show simple item record

Real-world experience with Ocrelizumab in the MSBase Registry

dc.contributor.authorButzkueven, H.
dc.contributor.authorSpelman, T.
dc.contributor.authorPatti, F.
dc.contributor.authorOzakbas, S.
dc.contributor.authorEichau, S.
dc.contributor.authorAlroughani, R.
dc.contributor.authorCraveiro, L.
dc.date.accessioned2020-06-21T12:26:00Z
dc.date.available2020-06-21T12:26:00Z
dc.date.issued2019
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.urihttps://hdl.handle.net/20.500.12712/10625
dc.description35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS -- SEP 11-13, 2019 -- Stockholm, SWEDENen_US
dc.descriptionLaureys, Guy/0000-0002-1708-4373en_US
dc.descriptionWOS: 000485303102197en_US
dc.description.abstract…en_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosis, Congrex Switzerland Ltden_US
dc.description.sponsorshipF. Hoffmann-La Roche Ltd.Hoffmann-La Rocheen_US
dc.description.sponsorshipSponsored by F. Hoffmann-La Roche Ltd. Editorial assistance was provided by Articulate Science, UK.en_US
dc.language.isoengen_US
dc.publisherSage Publications Ltden_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleReal-world experience with Ocrelizumab in the MSBase Registryen_US
dc.typeconferenceObjecten_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume25en_US
dc.identifier.startpage539en_US
dc.identifier.endpage540en_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record